Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000202729

Medchemexpress LLC Val-cit-pab-mmaf (sodium) | 98.4% | 1159.39 g/mol | C58H91N10NaO13 | 5 MG
SDP

Catalog No. 5000202729
Encompass_Preferred

Val-Cit-PAB-MMAF sodium is a drug-linker conjugate for antibody-drug conjugate (ADC) research that links the protease-cleavable peptide Val-Cit-PAB to the cytotoxic payload monomethyl auristatin F (MMAF). It is supplied as the sodium salt and intended for research use.

  • Protease-cleavable Val-Cit-PAB linker coupled to MMAF.
  • Intended for ADC research and conjugation workflows.
  • High purity suitable for research applications.
  • Soluble in DMSO at high concentration; in vivo formulations achieve ≥5 mg/mL with solvent mixtures.
  • Provided in small research pack sizes for preclinical experiments.

Catalog No. 50-002-02729 Supplier Medchemexpress LLC Supplier No. HY441775MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Val-Cit-PAB-MMAF sodium is a drug-linker conjugate for antibody-drug conjugate (ADC) research that links the protease-cleavable peptide Val-Cit-PAB to the cytotoxic payload monomethyl auristatin F (MMAF). It is supplied as the sodium salt and intended for research use.

  • Protease-cleavable Val-Cit-PAB linker coupled to MMAF.
  • Intended for ADC research and conjugation workflows.
  • High purity suitable for research applications.
  • Soluble in DMSO at high concentration; in vivo formulations achieve ≥5 mg/mL with solvent mixtures.
  • Provided in small research pack sizes for preclinical experiments.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.